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Abstract. 53 compounds with clinically established abil-
ity to cross or not to cross the blood-brain barrier by
passive diffusion were characterized by means of surface
activity measurements in terms of three parameters, i.e.,
the air-water partition coefficient, Kaw, the critical mi-
celle concentration, CMCD, and the cross-sectional area,
AD. A three-dimensional plot in which the surface area,
AD, is plotted as a function of K−1aw and CMCD shows
essentially three groups of compounds: (i) very hydro-
phobic compounds with large air-water partition coeffi-
cients and large cross-sectional areas, AD > 80 Å2 which
do not cross the blood-brain barrier, (ii) compounds with
lower air-water partition coefficients and an average
cross-sectional area, AD @ 50 Å2 which easily cross the
blood-brain barrier, and (iii) hydrophilic compounds
with low air-water partition coefficients (AD < 50 Å2)
which cross the blood-brain barrier only if applied at
high concentrations. It was shown that the lipid mem-
brane-water partition coefficient, Klw, measured previ-
ously, can be correlated with the air-water partition co-
efficient if the additional work against the internal lateral
bilayer pressure, pbi 4 34 ± 4 mN/m is taken into ac-
count. The partitioning into anisotropic lipid membranes
decreases exponentially with increasing cross-sectional
areas, AD, according to Klw 4 const. Kaw exp(−ADpbi/kT)
where kT is the thermal energy. The cross-sectional area
of the molecule oriented at a hydrophilic-hydrophobic
interface is thus the main determinant for membrane per-
meation provided the molecule is surface active and has
a pKa > 4 for acids and a pKa < 10 for bases.
Key words: Blood-brain barrier — Passive diffusion —
Monolayer-bilayer equivalence pressure — Internal lat-
eral bilayer pressure — Molecular size — Cross-sectional
area — Amphiphilicity — pKa — Drug screening
Introduction
Passive diffusion through the blood-brain barrier (BBB)
is the primary process of translocation from the blood
stream to the brain for the large majority of therapeutic
compounds. On a morphological level, the BBB consists
of the brain microvascular endothelium cells coupled by
tight junctions. On a molecular level, the principal dif-
fusion barrier consists of the lipid bilayer. The latter is a
highly anisotropic system which can be divided into at
least two distinct regions: (i) the polar head group-water
interface region, and (ii) the nonpolar hydrocarbon re-
gion. Deuterium nuclear magnetic resonance (2H-NMR)
(Seelig & Seelig, 1974; Seelig & Seelig, 1980) and neu-
tron diffraction measurements (Bu¨ldt et al., 1978) have
shown that the order of the hydrocarbon chains is rela-
tively high in the region near the lipid-water interface
and decreases strongly towards the bilayer center. These
results demonstrate that a bilayer cannot be properly
mimicked by an isotropic hydrocarbon phase. Indeed,
molecular dynamics simulations show that the rate of
diffusion differs considerably even in the membrane hy-
drocarbon region, being slow in the region of high order
and fast in the more disordered central part (Bassolino-
Klimas, Alper & Stouch, 1993).
Despite the well established anisotropy of lipid bi-
layers, the vast majority of investigations still relies on
the measurement of partition coefficients between an or-
ganic solvent (e.g., octanol, hexane or cyclohexane) and
water to assess the ability of a drug to diffuse through the
BBB. Interesting modifications of this approach are
HPLC methods where alkyl chains (e.g., C-18) (Kalis-
zan, 1990), or carboxyacyl phosphocholine chains (e.g.,
11-carboxylundecylphosphocholine) (Ong et al., 1995;
Yang et al., 1997) are covalently attached to sili-
ca. These systems show a limited anisotropy. However,
the packing density is still dictated by the chemistry of
the covalent linkage to silica and is distinctly lower thanCorrespondence to: A. Seelig
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the lipid packing density of a natural membrane (Demel
et al., 1975) or a bilayer model membrane (Seelig, 1987).
It is therefore not surprising that octanol-water partition
coefficients or lipophilicity parameters obtained from re-
versed phase HPLC measurements do not correlate sat-
isfactorily with the ability of a drug to diffuse through a
lipid membrane. Unfortunately, measurements of drug
binding and permeation through lipid bilayer vesicles are
generally time consuming.
As an alternative we have recently suggested a
method which does not involve lipids or organic solvents
(Seelig, Gottschlich & Devant, 1994). Our approach is
based on the measurement of the Gibbs adsorption iso-
therm of the molecule of interest. The Gibbs adsorption
isotherm is a quantitative measure for the tendency of a
drug to move to the air-water interface. The molecular
organization of drug molecules is not random but or-
dered such that the nonpolar parts extend into the air
while the hydrophilic parts maximize their contact with
the water phase. Since air has a similar dielectric con-
stant as the hydrocarbon region of the lipid membrane,
the air-water interface provides a good model for drug
orientation at the lipid-water interface. In addition, the
analysis of the Gibbs adsorption isotherm yields three
physical-chemical parameters of a drug molecule: (i) the
minimum concentration to induce surface activity, C0,
(ii) the surface area of the molecule at the air-water in-
terface, AD, and (iii) the critical micelle concentration,
CMC. These three parameters together with the ioniza-
tion constants of the drugs allow a separation of com-
pounds which reach the central nervous system (CNS)
and compounds which do not reach it with a predictive
success of better than 90% (Seelig et al., 1994).
The aim of the present work is, first, to provide a
better physical chemical understanding of the empirical
parameters used previously. This is possible by describ-
ing the Gibbs adsorption isotherm by means of the
Szyszkowski equation (cf. e.g., Rosen, 1989). The latter
provides an air-water partition coefficient, Kaw, which
correlates with the concentration of surface activity on-
set, C0. Secondly, we discuss the crucial importance of
the surface area requirement of the drug, AD, in connec-
tion with the bilayer anisotropy. The penetration of a
drug between the hydrocarbon chains requires energy
which is small for small molecules but can become pro-
hibitively high for molecules with a large cross section.
Finally, we extend our previous approach to a much
larger list of compounds.
Materials and Methods
MATERIALS
53 compounds were selected and classified according to their ability to
enter the CNS by passive diffusion through the BBB (Table). Com-
pounds identified to easily cross the BBB by passive diffusion are
denoted CNS+, those which cannot pass the BBB — or only to a very
limited extent — are denoted CNS− in the following.
Compounds which are therapeutically used for CNS indications
are considered as CNS+. In addition, the antihypertensive,
mCPP z 2HCl which undoubtedly acts by means of a central mecha-
nism (Fuller, 1986) and the analgesic, spiradoline (Von Voightlander &
Lewis, 1988) are also considered at CNS+.
HYDROPHOBIC CNS− COMPOUNDS WITH POTENTIAL
METABOLIC MODIFICATIONS
The characterization of hydrophobic compounds as CNS− is more com-
plex since they may undergo first-pass metabolism. We therefore dis-
cuss the potential metabolic modifications of these compounds and the
ability of their metabolites to cross the BBB.
Amiodarone undergoes first pass metabolism in the liver. The
unmetabolized form was nevertheless observed in different peripheral
organs, but not in the brain (Broekhuysen, Laruel & Sion, 1969). As-
temizole is also metabolized to a certain extent but relevant levels of the
unchanged substance were still detected in the plasma. No side effects
were observed, even at high concentrations (Seppala & Savolainen,
1982) which suggests that it does not reach the brain (Reece et al.,
1994). Asimadoline reaches the brain only to a limited extent as shown
by means of in vitro experiments (Barber et al., 1994). Domperidone
is a peripherally active dopamine antagonist. It does not induce the
central effects generally observed for centrally active dopamine an-
tagonists after intravenous injection (Reyntjens et al., 1978) and can
therefore be assumed not to reach the brain. Ebastine undergoes almost
complete first pass metabolism to carebastine after oral absorption.
Due to the absence of central effects it can be concluded that the latter
does not reach the brain. After parenteral injection ebastine is found, at
least initially, in high levels in the plasma (Martinez-Tobed et al., 1992;
Matsuda et al., 1994); however, no central effects have been observed
(Moragues & Roberts, 1990). Loperamide, a peripherally selective
opiate, shows plasma concentrations in the range of 2 ng/ml after oral
absorption in man (Heykants et al., 1974). Nevertheless, no central
opioid effects were observed, even at concentrations which distinctly
exceeded therapeutic concentrations (Schuermans et al., 1974). Terfen-
adine undergoes first pass metabolism to fexofenadine, a metabolite
containing a carboxylic acid group. However, the unmetabolized form
could still be detected in the blood and in a number of organs but not
in the brain (Leeson et al.,1982).
P-GLYCOPROTEIN SUBSTRATES
Since active efflux of compounds by P-glycoprotein can interfere with
passive diffusion we screened the structures of all compounds for po-
tential P-glycoprotein recognition patterns (Seelig, 1998). In brief,
substrate recognition patterns for P-glycoproteins have been proposed
to consist of two electron donor groups with a spatial separation of 2.5
± 0.3 Å (type I unit), two electron donor groups with a spatial sepa-
ration of 4.6 ± 0.6 Å (type II unit) or three electron donor groups with
a spatial separation of the outer two groups of 4.6 ± 0.6 Å (type II unit)
and to interact via hydrogen bonding with the transmembrane se-
quences of P-glycoprotein. The binding capacity of substrates is given
in terms of hydrogen bonding energy units (e.u.) in the Table. Only
compounds with e.u. ł 4 have been selected (Table) in order to mini-
mize the interference of active efflux by P-glycoprotein with passive
diffusion.
MEASUREMENT OF SURFACE ACTIVITY
Experiments were essentially performed as described previously
(Seelig et al., 1994). Water used for buffers and solutions was nano-
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pure with a resistivity of 17.5 MV z cm. 50 mM Tris buffer containing
114 mM NaCl was adjusted with HCl to the desired pH. Measurements
were performed at 23 ± 1°C.
Two home-built Teflon troughs (20 and 3 ml filling volume) were
used. For both troughs the surface pressure was measured with a
Wilhelmy plate. The electronically controlled equilibration time of the
spring to which the Wilhelmy plate is attached was much shorter for the
3 ml trough. As a consequence the measurement of a Gibbs adsorption
isotherm required only about 45 min in the 3 ml trough but about 4 hr
in the 20 ml trough.
To minimize evaporation both troughs were covered by a plexi-
glas hood. Drug solutions were injected in small increments by means
of a microsyringe to achieve the desired concentrations. In the case of
the 20 ml trough the added volume (maximum ł 2 ml) exactly com-
pensated the loss of solvent via evaporation. For the 3 ml trough, the
addition of solvent exceeded the loss of solvent by evaporation because
of the shorter measuring time. Concentrations were therefore corrected
for solvent addition as well as for evaporation.
For measurements in the 20 ml trough, stock solutions were 10−1–
10−3 M. Due to the relatively high concentrations, methanol was used
as solvent, independent of the respective water solubility of the com-
pound. Since methanol is itself surface active, the surface pressure, p,
was corrected for the surface pressure of methanol. For measurements
in the 3 ml trough the concentrations of the stock solutions were only
10−2–10−4 M and water could therefore by used as a solvent. The p/C
curves measured for compounds dissolved in water corresponded well
to the p/C curves of compounds dissolved in methanol and corrected
for the surface pressure of methanol. The reproducibility of the mea-
surements was ±5% including preparation of stock solution and buffer
solution.
MEASUREMENT OF THE LIPID MEMBRANE-WATER
PARTITION COEFFICIENT
Thermodynamics of drug partitioning into lipid bilayers will be dis-
cussed in detail elsewhere (A. Frentzel, X. Li, and A. Seelig, in prepa-
ration). In brief, the partitioning of drugs into sonified POPC vesicles
was measured by means of high sensitivity isothermal titration calo-
rimetry in buffer solution at 28°C. Using a Hamilton syringe coupled
with a stepping motor, 10 ml aliquots of the phospholipid vesicle sus-
pension (CL 4 33 mM) were injected into the calorimeter cell (volume
Vcell 4 1.3353 ml) containing the drug solution. Each injection gave
rise to an exothermic heat of reaction, produced by the partitioning of
the drug into the membrane (for further details cf. Wenk et al., 1997).
Asimadoline HCl (20 mM), and astemizole 2HCl (10 mM) were dis-
solved in 50 mM KH2PO4/K2H PO4 at pH 5.2 containing 114 mM NaCl.
The low pH was chosen because of aggregation problems at higher pH.
Desipramine HCl (50 mM), chlorpromazine HCl (50 mM), mequitazine
HCl (50 mM), perphenazine HCl (50 mM), and cis-flupenthixol HCl (10
mM) were dissolved in 50 mM Tris/HCl at pH 7.4 containing 114 mM
NaCl. Concentrations were chosen as low as possible in order to avoid
drug association in solution. For the evaluation of the lipid membrane-
water partition coefficients, Klw, regarded as a surface partition coef-
ficient, charge effects were taken into account by means of the Gouy-
Chapman theory (cf. McLaughlin, 1989).
Theory
The adsorption of an amphiphile at the air-water inter-
face lowers the surface tension of the buffer, g0, to a new
value g. The difference, p 4 g0 − g is the so-called
surface pressure. The thermodynamics of the adsorption
process is described by the Gibbs adsorption isotherm
which can be written as
dg 4 - RT (NAAS)−1 dlnC 4 −RTGdlnC 4 −dp (1)
where C is the concentration of the amphiphile in bulk
solution, RT is the thermal energy, NA is the Avogadro
number and AS is the surface area of the surface active
molecule at the interface. G 4 (NAAS)−1 is denoted sur-
face excess concentration. At low concentrations G in-
creases linearly with C, at high concentrations G reaches
a limiting value G‘. A plot of p vs. lnC should yield a
straight line as long as G is constant. AS was evaluated
from the slope
G‘ 4 (1/RT) dp/dlnC (2)
Integral forms of Eq. (1) can also be given. Particularly
useful for our purpose is the Szyszkowski equation (cf.
e.g., Rosen, 1989) which may be written as
p 4 RTG‘ ln (1 + KawC) (3)
where Kaw is the air-water partition coefficient. By fit-
ting Eq. (3) to the measured p/C curve using G‘, deter-
mined according to Eq. (2), the air-water partition coef-
ficient, Kaw, was evaluated.
Results
THE p/C ISOTHERM
Figure 1A shows the variation of the surface pressure, p,
with the logarithm of drug concentration, C, for astemi-
zole, a CNS−-compound, at pH 7.4 in buffer. The slope
of the linear part of the Gibbs adsorption isotherm
(dashed line) yields the surface excess concentration, G‘,
and, in turn, the surface area requirement of astemizole
(AS 4 94 ± 5 Å2). Figure 1B shows the same measure-
ment with the logarithmic scale replaced by a linear scale
for the concentration, C. The solid line represents the
binding isotherm calculated with the Szyszkowski equa-
tion (Eq. 3). The simulation uses the surface area as
determined from the Gibbs adsorption isotherm (Fig. 1A)
and yields a partition coefficient of Kaw 4 (31.6 ± 4.6)
104 M−1. The deviations at very low drug concentrations
are due to adsorption to the surface of the Teflon trough.
For more hydrophilic compounds adsorption is less pro-
nounced. Altogether 53 drugs were measured and ana-
lyzed by this approach and the data are summarized in
the Table.
At drug concentrations, C 4 1/Kaw the excess sur-
face concentration, G, reaches its half maximum value
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G‘/2 (cf. Fig. 1A). Previously (Seelig et al., 1994) we
introduced an empirical parameter Co, which was arbi-
trarily defined as the drug concentration at which the
surface pressure is 0.1 mN/m. The two parameters are
strongly correlated1. Since Kaw is physically better de-
fined we will use this parameter in the following. How-
ever, for compounds with low amphiphilicity or amphi-
philicity changing in the process of aggregation (cf. be-
low) the measured Gibbs adsorption isotherm cannot be
satisfactorily simulated. For these compounds neither As
nor Kaw can be properly determined and we therefore still
use the Co instead of the Kaw values.
As indicated in Fig. 1A two further parameters can
be derived from the Gibbs adsorption isotherm: the criti-
cal micelle concentration of a drug molecule, CMCD, and
the concentration of saturation, Csat. At the CMCD the
surface pressure, p, becomes independent of the drug
concentration indicating micelle formation. Micelles
formed by amphiphilic drugs are generally less stable
than micelles formed by detergents (Paula et al., 1995).
The pKa values of drugs tend to shift (to lower values for
bases and to higher values for acids) with increasing
concentration (Fischer, 1998; Mayer et al., 1988) leading
to further aggregation and finally precipitation. This
process is experimentally observed as a collapse of sur-
face pressure at the concentration of saturation,
Csat. The latter corresponds to about 3–4 times the
CMCD for compounds with average amphiphilicity (cf.
below), but can almost coincide with the CMCD for com-
pounds with low amphiphilicity.
THE CROSS-SECTIONAL AREA OF DRUGS
The large majority of drug molecules investigated here
carry charged groups. For charged molecules the surface
area, AS, depends on the pH of the solution. As an ex-
ample the pH dependence of the surface area of
hydroxyzine z 2HCl is shown in Fig. 2. Hydroxyzine
carries two tertiary amino groups with pKa,1 4 7.2 and
pKa,2 4 2.1 (Newton & Kluza, 1978). The surface area,
AS, is large at low pH due to charge repulsion effects and
decreases with increasing pH in a sigmoidal manner.
The inflection point of the curve agrees with the pKa1.
The tertiary amino groups of most drugs investigated
have pKa values of 7.5 to 8 at physiological salt concen-
trations (A. Seelig and S. Lotz, unpublished results).
Charge repulsion is therefore low at pH 8.0 and the sur-
face area measured corresponds to the true cross-
sectional area, AD, at least to a first approximation. Re-
sults in the Table show that for most compounds surface
areas measured at pH 7.4 and 8.0 are identical within
error limits.
THE K- 1aw/CMCD CALIBRATION DIAGRAM
Figure 3 correlates the Kaw values of the drugs measured
with the respective CMCDs. The compounds studied
previously (Seelig et al., 1994) are indicated as circles
and the new compounds as squares. Compounds which
easily cross the BBB by passive diffusion (CNS+ com-
pounds) are represented by open symbols, CNS− com-
pounds by closed symbols. Here Kaw−1 replaces the
1 A plot of logCo vs. logKaw yields a linear correlation (logKaw 4
−0.96(±0.29) − 1.11(±0.06)logCo) with a correlation coefficient of
0.971.
Fig. 1. A The Gibbs adsorption isotherm (p/log C) of astemizole mea-
sured in buffer solution at pH 7.4 (50 mM Tris/HCl, 114 mM NaCl). The
parameters derived from the Gibbs adsorption isotherm are: (i) the
concentration of surface activity onset, Co, (ii) the air-water partition
coefficient, Kaw, (iii) the critical micelle concentration, CMCD, (iv) the
concentration of saturation Csat, and (v) the surface excess concentra-
tion, G‘, from which the surface area of the molecule at the air-water
interface, As, can be determined. B: p/C − curve of astemizole, the solid
line represents the binding isotherm calculated with the Szyszkowski
equation (Eq. 3).
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empirical parameter C0 of our earlier work (Seelig et al.,
1994). The improved calibration diagram (Fig. 3) essen-
tially agrees with the calibration diagram presented pre-
viously (Seelig et al., 1994) and shows three regions
which differ with respect to the ability of compounds to
cross the BBB by passive diffusion. Region I contains
very hydrophobic drugs which fail to cross the BBB.
The central region II contains less hydrophobic drugs
which cross the BBB easily, with the exception of asi-
madoline (No. 37) for which passive diffusion is hin-
dered. As will be shown below, this unexpected behav-
ior can be explained by the large cross-sectional area of
this molecule. Region III contains hydrophilic drugs
which cross the BBB only if applied at high concentra-
tions (30–2400 mg/day). The only CNS+ compound ap-
plied at distinctly lower concentrations ( ~ 1 mg/day)
(Martindale, 1996) is clonidine (No. 19) which has, re-
cently been shown to be transported actively (Huwyler et
al., 1997). Three further compounds, salbutamol, suma-
triptan, and mequitazine (indicated by half-filled sym-
bols) are also applied at relatively low concentrations (c
ł 16 mg/day) and therefore clinically appear as CNS−
compounds.
THE K−1aw/CMCD/AD CALIBRATION DIAGRAM
During the course of our investigation it became clear
that the cross-sectional area of a drug molecule is an
important parameter in determining its ability to diffuse
through the BBB. This is illustrated by Fig. 4 where the
surface area, AD is plotted as a function of Kaw−1 and
CMCD. The hydrophobic CNS− compounds in region I
of Fig. 4 have large cross-sectional areas (average AD ~
105 Å2) while the more hydrophilic CNS+ compounds in
regions II and III have average cross-sectional areas of
AD ~ 52 Å2 and AD ~ 41 Å2, respectively. The only
CNS− compound found in region II (asimadoline) has a
cross-sectional area (AD 4 81 ± 1 Å2) which is distinctly
larger than that of the average CNS+ compound. This
suggests that passive diffusion of compounds with cross-
sectional areas AD > 80 Å2 is strongly reduced.
The importance of cross-sectional areas for passive
diffusion is further demonstrated by the following se-
quence of compounds with similar Kaw values but in-
creasing cross-sectional areas: cis-flupentixol (AD 4 60
Å2, 434.5 Da), asimadoline (AD 4 81 Å2, 414.5 Da,) and
astemizole (AD 4 94 Å2, 458.5 Da). The compounds
show decreasing abilities to reach the brain in the above
order. It is interesting to note that molecular mass does
not necessarily correlate with the cross-sectional area.
Fig. 2. The surface area, AS, of hydroxyzine measured as a function of
pH. Buffer solutions (Mes/HCl for pH 5 to 7 and Tris/HCl for pH 7 to
9) were 50 mM and contained 114 mM NaCl. The solid line was cal-
culated using ri 4 ro + const. (10pKa−pH/(1 + 10pKa−pH))2, where ri is
the radius of the cross-sectional area of the ionized form, ro, the radius
in the absence of charge repulsion, const. a constant and pKa the pKa1
of hydroxizine. The inflection point of the curve corresponds to pKa1.
At pH 8.0 charge repulsion effects between molecules at the air-water
interface are minimal and therefore the surface area, As, approximately
correspond to the cross-sectional area, AD, of the molecule.
Fig. 3. Kaw/CMCD — calibration diagram. The critical micelle con-
centration, CMCD, plotted as a function of the air-water partition co-
efficient, Kaw−1, for compounds with known ability to cross the BBB.
Region I contains the hydrophobic CNS− compounds, region II the
more hydrophilic CNS+ compounds, and region III the most hydro-
philic compounds which only reach the CNS if applied at relatively
high concentrations. The border between region I and II is indicated by
a dashed, and the border between region II and III by a dotted line. The
two border lines were determined empirically (Seelig et al., 1994).
Measurements were performed at pH 8.0 (50 mM Tris/HCl, 114 mM
NaCl). The numbers of the data points relate to the Table. Closed
symbols (d, j) indicate CNS− compounds, open symbols (s, h)
CNS+ compounds, and half-filled symbols (g, l) hydrophilic com-
pounds which are pharmacologically applied at low concentrations and
therefore appear as CNS−. Circles (d, g, s) represent compounds
measured previously (Seelig et al., 1994), and squares (h, l, j) new
compounds.
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THE INFLUENCE OF CHARGE ON PASSIVE DIFFUSION
THROUGH THE BBB
The charged substituents of the CNS+ compounds shown
in the Table are either tertiary amino groups with pKa <
9 under physiological conditions (150 mM NaCl) or a
sulfhydryl group (thiopental) with a pKa 4 7.4. To in-
vestigate the role of charge for membrane diffusion we
investigated the following compounds with pKa ł 4:
penicillin (pKa1 4 2.8), cetirizine (pKa1 4 3.7, pKa2 4
8.2), ampicillin (pKa1 4 3.0, pKa2 4 7.1), acrivastine
(pKa1 4 2.8, pKa2 4 7.5), ICI204448 (pKa1 4 3.1,
pKa2 4 8.0). The pKa values of the first two compounds
have been determined experimentally (ter Laak et al.,
1994; Tsuji et al., 1977), the others were estimated ac-
cording to the method of Perrin, Dempsey & Serjeant
(1981). Measurement of the Gibbs adsorption isotherm
shows that these compounds are all amphiphilic and are
located in regions II and III (cf. Table, not included in
Fig. 3) and are thus predicted to cross the BBB. Never-
theless these compounds are not found to penetrate into
the brain. We therefore conclude that compounds with
minimally one charge with a pKa < 4 for acids and cor-
respondingly a pKa > 10 for bases do not cross the BBB
by passive diffusion.
Discussion
53 compounds with known propensity to cross the BBB
were characterized with surface activity measurements.
Three parameters, the air-water partition coefficient,
Kaw, the critical micelle concentration, CMCD, and the
cross-sectional area, AD were deduced. Figure 3 demon-
strates that a Kaw−1 vs. CMCD diagram provides a useful
means to classify these drugs as CNS− and CNS+. Most
notable is region I which comprises a number of drugs
which are very hydrophobic according to most classical
criteria but still cannot pass the BBB. Inspection of Fig.
4 shows that these drugs are characterized by cross-
sectional areas AD ø 80 Å2. Combining this finding
with the specific structure of the lipid bilayer provides a
clue for their inability to cross the BBB by passive dif-
fusion.
THE ROLE OF THE MOLECULAR CROSS-SECTIONAL AREA
FOR PARTITIONING INTO THE LIPID MEMBRANE
Boguslavsky et al. (1994) have shown that the penetra-
tion of a molecule between the fatty acyl chains of a lipid
monolayer requires work, DW which is proportional to
the surface pressure, pm, of the monolayer and the cross-
sectional area, AD, of the penetrating compound
DW 4 ADpm (5)
The partition coefficient for the lipid monolayer is thus
proportional to exp(−ADpm/kT). For a lipid bilayer the
situation is similar. A penetrating substance has to per-Ta
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form work against the internal lateral pressure of the
lipid bilayer, pbi2
DW 4 AD pbi (6)
The lipid-water partition coefficient, Klw, is thus given by
Klw 4 K0exp(−AD pbi/kT) (7)
where K0 is a proportionality constant. Since the air-
water interface resembles the lipid-water interface with
respect to the gradient of dielectric constants, « (« @ 1 for
air, « @ 2 for the interior of the lipid membrane, and « @
80 for water) and since the surface pressure of the drug
monolayer is negligible at the concentration, l/Kaw, we
assume that K0 is proportional to Kaw. This assumption
was tested with a series of compounds for which both Klw
and Kaw are known. The lipid-water partition coeffi-
cients, Klw, were measured for small unilamellar 1-
palmitoyl-2-oleoyl-sn-phosphocholine (POPC) vesicles
with high sensitivity titration calorimetry (A. Frentzel, X.
Li, and A. Seelig; in preparation). Figure 5 shows a plot
of ln(Klw/Kaw) vs. AD. A linear regression analysis of the
experimental data yields a straight line with a slope of
p/kT 4 0.083 ± 0.014 [Å−2]. The internal lateral pres-
sure of the lipid bilayer3 is calculated as pbi 4 34 ± 4
mN/m which is in agreement with the monolayer-bilayer
(POPC) equivalence pressure, p 4 32 ± 1 mN/m deter-
mined earlier (Seelig, 1987).
An exponential decrease of the lipid-water partition
coefficients with increasing cross-sectional areas is sup-
ported by earlier measurements showing an exponential
decrease of binding (Gobas et al., 1988) to −, and per-
meation through (Lieb & Stein, 1986) lipid membranes
with increasing molecular volume.
At present the lateral packing density of the BBB is
not known, but an estimation is possible on the basis of
its cholesterol content. The content of cholesterol ex-
pressed as mole % of total lipids of endothelial mem-
branes amounts to ~ 30% (Simons & van Meer, 1988).
The cholesterol/phospholipid ratio of cerebral microves-
sels has been determined as 0.7 (mole/mole) (Mooradian
& Meredith, 1992) in close agreement with that of other
endothelial cells (Simons & van Meer, 1988). The effect
of cholesterol is to increase the order parameter of the
membranes in the liquid crystalline phase (Gally, Seelig
& Seelig, 1976). Upon addition of 30–40% cholesterol
to POPC membranes the lateral packing density has been
2 The effective internal lateral pressure in phospholipid bilayers was
previously estimated in comparison to lipid monolayers. A requirement
for the correspondence between the two is that the area per lipid mol-
ecule in the monolayer and the bilayer should be the same. Experimen-
tally the best correspondence was obtained for monolayers at a surface
pressure of 30–35 mN/m (for review see Marsh, 1996). A somewhat
wider surface pressure range (~ 28–40 mN/m) is discussed by Macdon-
ald (1996).
3 For low drug concentrations in the lipid membrane the lateral packing
density is assumed to remain constant to a first approximation.
Fig. 4. Kaw/CMCD/AD — calibration diagram
measured at pH 8.0 (50 mM Tris/HCl, 114 mM
NaCl). The air-water partition coefficient, Kaw−1 is
plotted in the x-, the critical micelle concentration,
CMCD, in the y- and the cross-sectional area, AD
in the z-axes. For symbols cf. legend to Fig. 3.
Compounds with low amphiphilicity or
amphiphilicity changing in the course of
aggregation are not included.
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shown to shift from 32 mN/m (Seelig, 1987) to 35 mN/m
(Demel et al., 1975; Taschner, 1993).
For a membrane with a lateral packing density of p
4 35 mN/m increasing the cross-sectional area of a mol-
ecule with a given partition coefficient, Kaw, from AD 4
52 Å2 (average area in region II) to 105 Å2 (average area
in region I) decreases the partition coefficient, Klw on
average by a factor of ~ 100. The limiting cross-sectional
area for passive diffusion through the BBB obtained
from the calibration diagram (Fig. 5) is ~ 80 Å2. For a
given Kaw an increase of the cross-section from 52 Å2 to
80 Å2 reduces the Klw by a factor of ~ 10.
Quite in contrast to the partitioning into lipid mem-
branes, partitioning into isotropic solvents like hexane or
octanol has been shown to increase with the molecular
volume of the compound (Gobas et al., 1988). Predic-
tions of passive diffusion through the BBB based on
partition coefficient measurements between water and
either isotropic solvents or loosely packed anisotropic
systems with low lateral packing densities (p < 32
mN/m) will therefore be misleading for molecules with
large cross-sectional areas.
THE ROLE OF AMPHIPHILICITY AND CHARGE FOR
MEMBRANE DIFFUSION
Amphiphilic molecules dissolved in water can achieve
segregation of their hydrophobic portion from the sol-
vent either by partitioning into the air-water interface or
by self-association. While both processes are primarily
entropy driven (hydrophobic effect), micelle formation
requires the additional action of an opposing force. In
the case of charged head groups it arises from electro-
static repulsion and in the case of hydrophilic head
groups from the preference for hydration (cf. Tanford,
1987). Figure 1A shows that Kaw < CMC. The free en-
ergy of micelle formation DGmic 4 RTln [CMC] (Tausk
et al., 1974) is therefore smaller than the free energy of
partitioning into the air-water interface, DGaw 4 −RT
lnKaw. The difference between the free energy of trans-
fer of a compound from the aqueous phase to the air-
water interface, and the free energy of micelle formation
directly reflects the amphiphilicity of a compound. We
therefore define amphiphilicity as
DDGam 4 DGaw − DGmic (8)
At constant charge amphiphilicity, DDGam, is propor-
tional to the distance between the charged residue and
the most remote hydrophobic residue, e.g., for fatty acids
the amphiphilicity increases by −1.14 ± 0.21 kJ/mole per
−CH2 group. The amphiphilicity observed for the drugs
investigated is in the range of DDGam 4 −3 to −11
kJ/mol. Most commonly amphiphilicity is around −5.6
kJ/mol (molecules on the diagonal between the lower left
and the upper right corner in Figure 3). Compounds
which lack amphiphilicity (DDGam @ 0) such as e.g.,
carmoxirol and pirenzepine are not surface active and are
thus unable to insert into a lipid membrane.4
Although amphiphilicity is a prerequisite for mem-
brane binding it is, per se, not sufficient to allow diffu-
sion through a membrane. For membrane permeation a
loss of charge, observed as a pKa shift upon membrane
binding (Beschiaschvili & Seelig, 1992) or a delocaliza-
tion of charge e.g., in the tetraphenyl phosphonium (Al-
tenbach & Seelig, 1985) or tetraphenyl borate ion (Seelig
& Ganz, 1991) is required. As seen in the Table com-
pounds which carry at least one stable charge pKa < 4 for
acids or pKa > 10 (no example shown) do not cross the
BBB.
In summary, we have shown that the drug partition
coefficient for lipid membranes, Klw, can be quantita-
tively predicted on the basis of the air-water partition
coefficient, Kaw, and the cross-sectional area of the mol-
ecule, AD, taking into account the internal lateral bilayer
pressure. We have further shown that permeation of a
drug molecule through the lipid membrane of the BBB is
4 Hydrophobic drugs with a low amphiphilicity tend to associate in
solution and can therefore not insert as monomers into membranes.
This is different for small molecules such as oxygen which dissolve in
aqueous solution and enter the membrane despite the lack of amphi-
philicity.
Fig. 5. The natural logarithm of the quotient of the lipid membrane-
water partition coefficient, Klw, and the air-water partition coefficient,
Kaw, plotted as a function of the cross-sectional area. A linear regres-
sion analysis yields a straight line with a slope of pbi/kT 4 0.084 ±
0.015 [Å−2] and the internal lateral bilayer pressure is calculated as pbi
4 34 ± 4 mN/m. The compounds measured are: chlorpromazine HCl
(3), cis-flupentixol 2HCl (10), desipramine HCl (21), mequitazine HCl
(25), asimadoline HCl (37), and astemizole 2HCl (38). All parameters
were measured at pH 7.4 (50 mM Tris/HCl, 114 mM NaCl), with the
exception of Klw for astemizole and asimadoline which were measured
at pH 5.2 due to solubility problems. Electrostatic effects were taken
into account by means of the Gouy-Chapman theory.
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optimal if (i) amphiphilicity is DDGam > −3 kJ/mole, (ii)
the Kaw value is in the range of 105–103 M−1, (iii) the
cross-sectional area is AD < 80 Å2 and (iv) the ionization
constants are pKa > 4 for acids and pKa < 10 for bases.
The present method is suited as a fast screening method
and is superior in its predictive power to a single param-
eter organic phase/water partition equilibrium measure-
ment.
We thank Sandra Lotz and Thomas Alt for expert technical assistance
and Dr. Heinrich Stahl for helpful discussions. This research was sup-
ported by the Swiss National Science Foundation Grant 31.42058.94
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